Biocon eyeing acquisitions in US, Europe

By IANS

New Delhi : Indian biotechnology major Biocon is eyeing acquisitions in the US and European markets by the end of current fiscal (2007-08), its chairman said Monday.

---

Support TwoCircles

---

“We are looking at US, Europe and some of the emerging markets,” Kiran Mazumdar-Shaw told reporters on the sidelines of the India Economic Summit currently underway here.

“With the rupee appreciating, you are going to be able to acquire companies,” she said.

Mazumdar-Shaw also said Biocon is looking at the proposed acquisitions on a case-by-case basis and that the company has six products in its discovery pipeline, out of which three are at the pre-clinical stage.